Our findings provide a new mechanism for understanding MSCs’ osteogenic differentiation and the regulation of bone formation, and highlight MACF1 as a potential therapeutic target for degenerative bone diseases such as osteoporosis. This evidence concerns the gene MACF1 and osteoporosis.